Nanomaterials,
Journal Year:
2023,
Volume and Issue:
13(19), P. 2725 - 2725
Published: Oct. 8, 2023
A
biofilm
is
a
microbial
community
formed
by
bacteria
that
adsorb
on
the
surface
of
tissues
or
materials
and
wrapped
in
extracellular
polymeric
substances
(EPS)
such
as
polysaccharides,
proteins
nucleic
acids.
As
protective
barrier,
EPS
can
not
only
prevent
penetration
antibiotics
other
antibacterial
agents
into
biofilm,
but
also
protect
from
attacks
human
immune
system,
making
it
difficult
to
eradicate
biofilm-related
infections
posing
serious
threat
public
health.
Therefore,
there
an
urgent
need
develop
new
efficient
antibiofilm
drugs.
Although
natural
enzymes
(lysozyme,
peroxidase,
etc.)
antimicrobial
peptides
have
excellent
bactericidal
activity,
their
low
stability
physiological
environment
poor
permeability
biofilms
limit
application
antibiofilms.
With
development
science,
more
nanomaterials
are
being
designed
be
utilized
for
applications.
Nanomaterials
great
prospects
because
good
biocompati-bility,
unique
physical
chemical
properties,
adjustable
nanostructure,
high
non-proneness
induce
bacterial
resistance.
In
this
review,
with
composite
antibiofilms
theme,
we
summarize
research
progress
three
types
nanomaterials,
including
organic
materials,
inorganic
organic–inorganic
hybrid
used
non-phototherapy
phototherapy
modes
action.
At
same
time,
challenges
directions
these
therapy
discussed.
It
expected
will
provide
ideas
design
safe
materials.
Frontiers in Cellular and Infection Microbiology,
Journal Year:
2023,
Volume and Issue:
13
Published: April 6, 2023
Bacterial
biofilms
are
complex
microbial
communities
encased
in
extracellular
polymeric
substances.
Their
formation
is
a
multi-step
process.
Biofilms
significant
problem
treating
bacterial
infections
and
one
of
the
main
reasons
for
persistence
infections.
They
can
exhibit
increased
resistance
to
classical
antibiotics
cause
disease
through
device-related
non-device
(tissue)
-associated
infections,
posing
severe
threat
global
health
issues.
Therefore,
early
detection
search
new
alternative
treatments
essential
suppressing
biofilm-associated
In
this
paper,
we
systematically
reviewed
biofilms,
associated
methods,
potential
treatment
strategies,
aiming
provide
researchers
with
latest
progress
biofilms.
Advanced Science,
Journal Year:
2023,
Volume and Issue:
10(13)
Published: Feb. 27, 2023
With
the
threat
posed
by
drug-resistant
pathogenic
bacteria,
developing
non-antibiotic
strategies
for
eradicating
clinically
prevalent
superbugs
remains
challenging.
Ferroptosis
is
a
newly
discovered
form
of
regulated
cell
death
that
can
overcome
drug
resistance.
Emerging
evidence
shows
potential
triggering
ferroptosis-like
antibacterial
therapy,
but
direct
delivery
iron
species
inefficient
and
may
cause
detrimental
effects.
Herein,
an
effective
strategy
to
induce
bacterial
nonferrous
coordinating
single-atom
metal
sites
(e.g.,
Ir
Ru)
into
sp
Antibiotics,
Journal Year:
2025,
Volume and Issue:
14(2), P. 207 - 207
Published: Feb. 18, 2025
The
rapid
rise
of
antibiotic
resistance
has
become
a
global
health
crisis,
necessitating
the
development
innovative
strategies
to
combat
multidrug-resistant
(MDR)
pathogens.
Nanomaterials
have
emerged
as
promising
tools
in
this
fight,
offering
unique
physicochemical
properties
that
enhance
efficacy,
overcome
mechanisms,
and
provide
alternative
therapeutic
approaches.
This
review
explores
diverse
nanomaterial-based
used
resistance,
focusing
on
their
mechanisms
action
practical
applications.
such
metal
nanoparticles,
carbon-based
nanomaterials,
polymeric
nanostructures
exhibit
antibacterial
through
various
pathways,
including
generation
reactive
oxygen
species
(ROS),
disruption
bacterial
membranes,
enhancement
delivery.
Additionally,
ability
nanomaterials
bypass
traditional
biofilm
formation
efflux
pumps,
been
demonstrated
numerous
studies.
also
discusses
synergistic
effects
observed
when
are
combined
with
conventional
antibiotics,
leading
increased
susceptibility
reduced
required
dosages.
By
highlighting
recent
advancements
clinical
applications
nanomaterial-antibiotic
combinations,
paper
provides
comprehensive
overview
how
reshaping
future
therapies.
Future
research
directions
challenges,
toxicity
scalability,
addressed
guide
safer,
more
effective
treatments.
Antibiotics,
Journal Year:
2022,
Volume and Issue:
12(1), P. 67 - 67
Published: Dec. 30, 2022
Infections
caused
by
antibiotic-resistant
bacteria
(ARB)
are
one
of
the
major
global
health
challenges
our
time.
In
addition
to
developing
new
antibiotics
combat
ARB,
sensitizing
or
pursuing
alternatives
existing
promising
options
counter
antibiotic
resistance.
This
review
compiles
most
anti-ARB
strategies
currently
under
development.
These
include
following:
(i)
discovery
novel
modification
antibiotics,
screening
small-molecule
libraries,
exploration
peculiar
places;
(ii)
improvement
in
efficacy
through
metabolic
stimulation
loading
a
novel,
more
efficient
delivery
systems;
(iii)
development
conventional
such
as
bacteriophages
and
their
encoded
endolysins,
anti-biofilm
drugs,
probiotics,
nanomaterials,
vaccines,
antibody
therapies.
Clinical
preclinical
studies
show
that
these
treatments
possess
great
potential
against
ARB.
Some
products
expected
become
commercially
available
near
future.
Pharmaceutics,
Journal Year:
2023,
Volume and Issue:
15(1), P. 259 - 259
Published: Jan. 11, 2023
Numerous
antimicrobial
drugs
have
been
prescribed
to
kill
or
inhibit
the
growth
of
microbes
such
as
bacteria,
fungi,
and
viruses.
Despite
known
therapeutic
efficacy
these
drugs,
inefficient
delivery
could
result
in
an
inadequate
index
several
side
effects.
In
order
overcome
this
adversity,
present
study
investigated
antibiotic
drug
loading
zeolitic
imidazolate
frameworks
(ZIFs),
association
with
ZnO
nanoparticles
properties.
economic
synthesis
method,
surface
was
first
converted
ZIF-8
2-methylimidazole
a
ligand,
resulting
ZnO@ZIF-8
structure.
This
system
enables
high
drug-loading
efficiency
(46%)
drug,
ciprofloxacin,
within
pores
ZIF-8.
provides
control
release
active
moieties,
simulated
body-fluid
conditions,
maximum
67%
released
96
h.
The
antibacterial
activities
CIP-ZnO@ZIF-8
were
tested
against
Gram-positive
Staphylococcus
aureus
strain
Gram-negative
Pseudomonas
aeruginosa
strain,
showing
good
inhibition.
obtained
by
combining
ciprofloxacin
minimal
inhibitory
concentration
(MIC)
that
10
times
lower
than
for
S.
200
P.
aeruginosa,
suggesting
may
potential
application
prolonged
treatment.
Advanced Healthcare Materials,
Journal Year:
2024,
Volume and Issue:
13(18)
Published: March 14, 2024
Bacterial
infections
in
wounds
continue
to
be
a
major
challenge
clinical
settings
worldwide
and
represent
significant
threat
human
health.
This
work
proposes
novel
expandable
versatile
methods
for
solidifying
sodium
alginate
(SA)
with
metal
ions
(such
as
Fe
Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology,
Journal Year:
2024,
Volume and Issue:
16(3)
Published: May 1, 2024
Abstract
The
misuse
of
antibiotics
has
led
to
increased
bacterial
resistance,
posing
a
global
public
health
crisis
and
seriously
endangering
lives.
Currently,
antibiotic
therapy
remains
the
most
common
approach
for
treating
infections,
but
its
effectiveness
against
multidrug‐resistant
bacteria
is
diminishing
due
slow
development
new
increase
drug
resistance.
Consequently,
developing
a\ntimicrobial
strategies
improving
efficacy
combat
infection
become
an
urgent
priority.
emergence
nanotechnology
revolutionized
traditional
treatment,
presenting
opportunities
refractory
infection.
Here
we
comprehensively
review
research
progress
in
nanotechnology‐based
antimicrobial
delivery
highlight
diverse
platforms
designed
target
different
resistance
mechanisms.
We
also
outline
use
combining
with
other
therapeutic
modalities
enhance
drug‐resistant
infections.
These
innovative
have
potential
susceptibility
overcome
Finally,
challenges
prospects
application
nanomaterial‐based
combating
are
discussed.
This
article
categorized
under:
Biology‐Inspired
Nanomaterials
>
Nucleic
Acid‐Based
Structures
Therapeutic
Approaches
Drug
Discovery
Nanomedicine
Infectious
Disease
Journal of Nanobiotechnology,
Journal Year:
2023,
Volume and Issue:
21(1)
Published: Sept. 8, 2023
Abstract
Bacterial
infection
has
been
a
major
threat
to
worldwide
human
health,
in
particular
with
the
ever-increasing
level
of
antimicrobial
resistance.
Given
complex
microenvironment
bacterial
infections,
conventional
use
antibiotics
typically
renders
low
efficacy
control,
thus
calling
for
novel
strategies
effective
antibacterial
therapies.
As
an
excellent
candidate
delivery,
mesoporous
silica
nanoparticles
(MSNs)
demonstrate
unique
physicochemical
advantages
Beyond
delivery
capability,
extensive
efforts
have
devoted
engineering
MSNs
be
bioactive
further
synergize
therapeutic
effect
control.
In
this
review,
we
critically
reviewed
essential
properties
that
benefit
their
application,
followed
by
themed
summary
manipulating
into
nanoplatforms
enhanced
The
chemically
functionalized
platform,
photo-synergized
physical
platform
and
targeting-directed
are
introduced
details,
where
clinical
translation
challenges
these
MSNs-based
briefly
discussed
afterwards.
This
review
provides
critical
information
emerging
trend
turning
bioinert
agents,
paving
way
inspire
translate
nanotherapies
combating
diseases.
Graphical